I am currently a resident in Haematology at the Karolinska University Hospital where I meet patients with lymphoma and other haematological diseases on a daily basis. I finished my PhD-studies at the Department of Oncology, Lund University, in 2016 and have worked with lymphoma research since 2010. In September 2017 I joined the Cancer Epidemiology group at KEP as a post-doc.
MD, Lund University, 2014
PhD, Lund University, 2016, Thesis title: Burkitt lymphoma and diffuse large B-cell lymphoma – therapeutic strategies and pathogenetic mechanisms
Post-doc, Karolinska Institutet, since 2017
My research focus is on malignant lymphomas, with a special interest in aggressive subtypes such as diffuse large B-cell lymphoma, Burkitt lymphoma and primary mediastinal B-cell lymphoma. By using real-world data from national lymphoma registers linked to other databases I investigate the impact of prognostic factors, treatment and outcomes among patients with lymphoma in a population-based setting.
Further, I am involved in organising the set-up of BioLymph, a collaborative project that will prospectively collect blood samples for NGS sequencing and cell-free tumour DNA for all patients with newly diagnosed lymphomas at the Karolinska University hospital. I also participate as a co-investigator in several ongoing clinical trials at the department of Haematology.
Mentor at the course in professional development for medical student at Karolinska institutet since 2017